•
Mar 31, 2023

AN2 Therapeutics Q1 2023 Earnings Report

EPS
-$0.79
Previous year: -$2.98
-73.5%
Cash and Equivalents
$26.7M
Previous year: $82.5M
-67.6%
Total Assets
$91.1M
Previous year: $121M
-24.4%

AN2 Therapeutics

AN2 Therapeutics